研究单位:[1]Huazhong University of Science and Technology[2]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology Wuhan,Hu Bei,China,430000
研究目的:
An open label, single-arm clinical study evaluating the safety and efficacy of IBI346 infusion in relapsed/refractory multiple myeloma